维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="FRIBOULET L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas:critical role in resistance to Toll-like receptor 3mediated apoptosis显示文摘	Friboulet L Pioche-Durieu C Rodriguez S	2008	Neoplasia2008，10，11：	1
2	ERCC1 isoform expression and DNA repair in nun-small-cell lung cancer 显示文摘	Friboulet L Olaussen K A Pignon JP	2013	N Engl J Med2013，368，12：	1
3	Recurrent Over- expression of c-IAP2 in EBV-Associated Nasopharyngeal Carcinomas:Critical Role in Resistance to Toll-like Receptor 3-Mediated Apoptosis 显示文摘	Friboulet L Pioche-Durieu C Rodriguez S	2008	Neoplasia2008，10，11：	1
4	The ALK inhibitor cer- itinib overcomes crizotinib resistance in non-small cell lung canc- er 显示文摘	Friboulet L Li N Katayama R	2014	Cancer Discov2014，4，：	1
5	ERCC1 function in nuclear excision and interstrand erosslink repair pathways is media- ted exclusively by the ERCC1-202 isoform显示文摘	Friboulet L Postel-Vinay S Sourisseau T	2013	Cell Cycle2013，12，20：	1
6	Molecu- lar characteristics of ERCC1-Negative versus ERCC1- Positive tumors in resected NSCLC显示文摘	Friboulet L Barrios-Gonzales D Commo F	2011	Clin Cancer Res2011，17，17：	1
7	ERCC1 istbrm expts- sion and DNA repair in non - samll cell lung cancer 显示文摘	Friboulet L Friboulet KA Pignon JP	2013	N Engl J Med2013，368，：	1
8	The ALK inhibitor cer- itinib overcomes crizotinib resistance in non-small cell lung cancer 显示文摘	Friboulet L Li N Katayama R	2014	Cancer Discov2014，4，6：	1
9	ERCC1 isoformexpression and DNA repair in non-small-cell lung cancer 显示文摘	Friboulet L Olaussen KA Pignon JP	2013	N Engl J Med2013，368，12：	1
10	The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer显示文摘	Friboulet L Li N Katayama R	2014	Cancer Discov、2014，4，6：	1
11	Two Novel ALKMutations Mediate Acquired Resistance to the Next-GenerationALK Inhibitor Alectinib显示文摘	Katayama R Friboulet L Koike S	2014	Clin Cancer Res2014，20，22：	1
12	The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer显示文摘	Friboulet L Li Nanxin Katayama R	2014	Cancer Diseov2014，4，6：	1
13	Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites:production of a catalytic antibody with a cholinesterase activity显示文摘	IZADYAR L FRIBOULET A REMY M H		Proceedings of the National Academy of Sciences(USA)0，，：	1
14	ERCC 1 isoform ex- pression and DNA repair in non-small-cell lung cancer 显示文摘	Friboulet L Olaussen KA Pignon JP	2013	N Engl J Med2013，368，12：	1
15	ERCC1 isoform expression and DNA repair and in non-small-cell lung cancer显示文摘	Friboulet L Olaussen K A Pignon J P		0，，12：	1
16	Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3- mediated apoptosis显示文摘	Friboulet L Pioche-Durieu C Rodriguez S et ai	2008	Neoplasia2008，0，11：	1
17	The ALK inhibi- tor ccritinib overcomes erizotinih resistance in non-snaall-celI-lung cancer显示文摘	FRIBOULET L L1 N KATAYAMA R	2014	CancerDiscov2014，4，12：	1
18	Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC显示文摘	Friboulet L Barrios-Gonzales D Commo F	2011	Clin Cancer Res2011，17，17：	1
19	ERCC1 isoform expression and DNA repair in non-small-cell lung cancer显示文摘	Friboulet L Olaussen KA Pignon JP	2013	N Engl J Med2013，368，12：	1
20	Resensitization to Crizotinib by the Lorlatinib ALK resistance mutation L1198F显示文摘	Shaw AT Friboulet L Leshchiner I	2016	N Engl J Med2016，374，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示